![]() |
Volumn 43, Issue 4, 2002, Pages 315-318
|
In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY Antimicrobial Surveillance Program (1998-1999)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIPROFLOXACIN;
GATIFLOXACIN;
LEVOFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TROVAFLOXACIN;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
ASIA;
BACTERIAL STRAIN;
BACTERIUM ISOLATE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
HAEMOPHILUS INFLUENZAE;
IN VITRO STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
NONHUMAN;
PRIORITY JOURNAL;
RESPIRATORY TRACT INFECTION;
STREPTOCOCCUS PNEUMONIAE;
ANTI-INFECTIVE AGENTS;
ASIA;
DRUG RESISTANCE, BACTERIAL;
FLUOROQUINOLONES;
HAEMOPHILUS INFLUENZAE;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
MORAXELLA (BRANHAMELLA) CATARRHALIS;
POPULATION SURVEILLANCE;
RESPIRATORY TRACT INFECTIONS;
STREPTOCOCCUS PNEUMONIAE;
|
EID: 0036334078
PISSN: 07328893
EISSN: None
Source Type: Journal
DOI: 10.1016/S0732-8893(02)00404-2 Document Type: Article |
Times cited : (5)
|
References (15)
|